HB 1239 — Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

HB 1239 (Amendment SA0095)

Amendment SA0095 text of HB 1239.

Senate Judiciary 1

Amendment No. 1 to SB0421

The document summary and details above are public. The full text is available to signed-in accounts.